Search Within

Lisa Bodei

  1. "Center for Molecular Imaging and Biotechnology (CMIB)"
Formats
  1. Book Section (8)
  2. Journal Article (8)
  3. Review (3)
  4. Book Whole (1)
  5. Editorial (1)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (21)
  2. GSK Faculty (21)
  3. Molecular Imaging and Therapy Service (21)
  4. Radiology, Department of (21)
  5. Sloan Kettering Institute Postdocs (21)
  6. Radiochemistry and Imaging Sciences Service (19)

More Groups

People
  1. Jason Lewis (18)
  2. Serge Lyashchenko (5)
  3. Heiko Schoder (4)
  4. Joseph O'Donoghue (4)
  5. Neeta Pandit-Taskar (4)
  6. Diane Reidy (3)

More People

Years
  1. 2024 (2)
  2. 2023 (9)
  3. 2022 (2)
  4. 2021 (3)
  5. 2020 (3)
  6. 2019 (2)
Publications
  1. Radiopharmaceutical Therapy (9)
  2. European Journal of Nuclear Medicine and Molecular Imaging (3)
  3. Journal of Nuclear Medicine (2)
  4. Clinical Cancer Research (1)
  5. Journal of Clinical Endocrinology and Metabolism (1)
  6. Journal of the Endocrine Society (1)

More Publications

Publishers
  1. Springer (12)
  2. Society of Nuclear Medicine (2)
  3. American Association for Cancer Research (1)
  4. Elsevier Science, Inc. (1)
  5. Endocrine Society (1)
  6. Lippincott Williams & Wilkins (1)

More Publishers

Results (21)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Case study #2: Disialoganglioside GD2 as a target for radiopharmaceutical therapy
    Book Section

    Cheung, N. K. V.; Kramer, K.; Modak, S.; Kushner, B. H.; Ahmed, M.; Santich, B.; Cheal, S.; Larson, S.
    In Bodei, L.; Lewis, J. S.; Zeglis, B. M. (Eds.) Radiopharmaceutical Therapy (2023)

    Fulltext@MSK | Save
  • Radiotheranostics in oncology: Current challenges and emerging opportunities
    Review

    Bodei, L.; Herrmann, K.; Schöder, H.; Scott, A. M.; Lewis, J. S.
    Nature Reviews Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Delta-like ligand 3–targeted radioimmunotherapy for neuroendocrine prostate cancer
    Journal Article

    Korsen, J. A.; Gutierrez, J. A.; Tully, K. M.; Carter, L. M.; Samuels, Z. V.; Khitrov, S.; Poirier, J. T.; Rudin, C. M.; Chen, Y.; Morris, M. J.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2022)

    Fulltext@MSK | Save
  • Synergism of checkpoint inhibitors and peptide receptor radionuclide therapy in the treatment of pituitary carcinoma
    Journal Article

    Lin, A. L.; Tabar, V.; Young, R. J.; Cohen, M.; Cuaron, J.; Yang, T. J.; Rosenblum, M.; Rudneva, V. A.; Geer, E. B.; Bodei, L.
    Journal of the Endocrine Society (2021)

    Fulltext@MSK | Save
  • A simple strategy to reduce the salivary gland and kidney uptake of PSMA-targeting small molecule radiopharmaceuticals
    Journal Article

    Kalidindi, T. M.; Lee, S. G.; Jou, K.; Chakraborty, G.; Skafida, M.; Tagawa, S. T.; Bander, N. H.; Schoder, H.; Bodei, L.; Pandit-Taskar, N.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2021)

    Fulltext@MSK | Save
  • γ-tocotrienol-loaded liposomes for radioprotection from hematopoietic side effects caused by radiotherapeutic drugs
    Journal Article

    Lee, S. G.; Kalidindi, T. M.; Lou, H.; Gangangari, K.; Punzalan, B.; Bitton, A.; Lee, C. J.; Vargas, H. A.; Park, S.; Bodei, L.; more...
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • The future of nuclear medicine, molecular imaging, and theranostics
    Editorial

    Weber, W. A.; Czernin, J.; Anderson, C. J.; Badawi, R. D.; Barthel, H.; Bengel, F.; Bodei, L.; Buvat, I.; DiCarli, M.; Graham, M. M.; more...
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Comparison of (68)Ga-DOTA-JR11 PET/CT with dosimetric (177)Lu-satoreotide tetraxetan ((177)Lu-DOTA-JR11) SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy
    Journal Article

    Krebs, S.; O'Donoghue, J. A.; Biegel, E.; Beattie, B. J.; Reidy, D.; Lyashchenko, S. K.; Lewis, J. S.; Bodei, L.; Weber, W. A.; Pandit-Taskar, N.
    European Journal of Nuclear Medicine and Molecular Imaging (2020)

    Fulltext@MSK | Save
  • Approach to the treatment of a patient with an aggressive pituitary tumor
    Review

    Lin, A. L.; Donoghue, M. T. A.; Wardlaw, S. L.; Yang, T. J.; Bodei, L.; Tabar, V.; Geer, E. B.
    Journal of Clinical Endocrinology and Metabolism (2020)

    Fulltext@MSK | Save
  • Phase I trial of well-differentiated neuroendocrine tumors (NETs) with radiolabeled somatostatin antagonist (177)Lu-satoreotide tetraxetan
    Journal Article

    Reidy-Lagunes, D.; Pandit-Taskar, N.; O'Donoghue, J. A.; Krebs, S.; Staton, K. D.; Lyashchenko, S. K.; Lewis, J. S.; Raj, N.; Gönen, M.; Lohrmann, C.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save